The Residency Towers. 15 th - 16 th September. Coimbatore, Tamilnadu. 6 th Annual Conference Society for Heart Failure and Transplantation

Size: px
Start display at page:

Download "The Residency Towers. 15 th - 16 th September. Coimbatore, Tamilnadu. 6 th Annual Conference Society for Heart Failure and Transplantation"

Transcription

1 6 th Annual Conference Society for Heart Failure and Transplantation The Residency Towers Coimbatore, Tamilnadu 15 th - 16 th September

2 PRESIDENT Dr. JOSE CHACKO PERIAPURAM SECRETARY Dr. JABIR ABDULLAKUTTY PRESIDENT ELECT Dr. P P MOHANAN VICE PRESIDENT Dr. V NANDAKUMAR Dr. RONY MATHEW JOINT SECRETARY Dr. RAJAGOPAL PAST PRESIDENT Dr. K VENUGOPAL TREASURER Dr. PRAVEEN G PAI EXECUTIVE COMMITTEE MEMBERS Dr. A V KANNAN Dr. CHANDRASEKAR Dr. HARIKRISHNAN S Dear Colleagues, It gives me great pleasure to invite you to Coimbatore for the 6th Annual meeting of the Society for Heart failure and Transplantation - SFHFTCON 2018, on the 15th and 16th of September Heart failure burden is on the constant increase in our country and over the last few years this is being increasingly recognized as a sub specialty. Heart team approaches for better medical management and interventions have proved to improve the quality of life of these patients. India has also seen a tremendous growth in transplant and mechanical support apart from electro - physiological procedures in the past decade. The SFHFTCON provides a common platform for all personnel involved in the management of heart failure and transplantation. The 6th annual meeting will provide a comprehensive review of all aspects of this growing sub speciality with specific emphasis on the issues governing the Indian scenario. We have an excellent international and national faculty to deliberate on various topics which has been painstakingly put-together by the scientific committee. Coimbatore is known for its hospitality and warmth and I assure you that your visit will be useful and enriching. Kindly register early. Dr. HARILAL V NAMBIAR Dr. JACOB ABRAHAM Dr. JAMES THOMAS Dr. RAJESH RAMANKUTTY Dr. STIGY JOSEPH Dr. V K CHOPRA Dr Jose Chacko Periapuram President Dr P Chandrasekar Organising Secretary

3 INTERNATIONAL FACULTY Dr Richard C Daly Director, Heart & Lung Transplantation, Mayo Clinic, USA Dr Catherine D Sudarshan Consultant Cardiothoracic Surgeon, Royal Papworth Hospital, NHS, UK Dr Jai S Raman Professor of Cardiothoracic Surgery, Oregon Health & Science University, USA Dr K Chandrasekaran Professor of Cardiology, Mayo Clinic, USA NATIONAL FACULTY: Dr Abhilash G P Dr Abraham Oomen Dr Ajit Kumar V K Dr Ajit Thachil Dr Alla Gokhale Dr Ambuj Roy Dr Amit Vora Dr Anway Mulay Dr Arun Gopi Dr S M Ashraf Dr Bahuleyan C G Dr K R Balakrishnan Dr V V Bashi Dr Bhageerath Dr K M Cherian Dr Cibu Mathew Dr Dhiren Shah Dr Feroz Aziz Dr Geevar Zachariah Dr George Koshy Dr Gopichand Mannam Dr Govind Unni Dr Hisham Ahmed Dr P B Jayagopal Dr T K Jayakumar Dr Jayaprakash Dr Julius Ponnen Dr Karunadas Dr Meherwal Dr Kunal Sarkar Dr Madhu Sreedharan Dr Madhushankar Dr Manoj Durairaj Dr Milind Hote Dr D S Nagesh Dr Natarajan K U Dr Padmanabhan Dr Paul Ramesh Dr Prashanth Vaijayanath Dr Praveen Varma Dr Rajagopal Dr Rajan Sethurathnam Dr Rajendiran Dr Rajiv E Dr Ramprakash Dr Sandeep Attawar Dr Sandeep Seth Dr C G Sajeev Dr Shiv Nair Dr Sumithran G Dr Sunder T Dr Sunita Vishwanathan Dr K Suresh Dr Suresh Rao Dr Yugal Mishra

4 PRELIMINARY SCIENTIFIC SCHEDULE Day 1: 15 th Sept 2018 (Saturday) Emerging Data and Therapeutic Implication Stone liver - heart in danger Donation after circulatory determined death (DCD): A game changer Ivabradine and Beta blockers - early in Heart Failure Atrial flow regulators in Resistant Heart Failure Empaglifozin - Is it a diabetic drug in Heart Failure or Heart Failure drug in Diabetes Heterotopic Heart Transplantation Chronic Thrombo-embolism - Pulmonary Artery Hypertension Evaluation and non-surgical management of CTE - PAH Surgical indications and approach in CTE - PAH Asessment of RV function.i still Prefer Echo over MRI Heart Transplantation When to Transplant and when to insert a VAD Combined Heart & Liver Transplantation : Tips and Challenges - Mayo experience Immunologic profiling of a sensitized patient Imaging techniques post-transplant Post Transplant Critical care Post-Transplant immunosupression, What is new? Debates and Controversies Debate 1: Ischemic Mod MR. I will tackle MR Debate 1: Ischemic Mod MR. I will leave it. Debate 2: HFrEF - My first choice is ACEI / ARB Debate 2: HFrEF - My first choice is ARNI Controversy 1: ICD or Wearable Vest in patients awaiting heart transplant Controversy 2: NT-ProBNP guided management in HF- does it alter outcomes? Controversy 3: Vaccines to improve outcomes in Heart Failure Controversy 4: Hydralazine with Isorbide dinatrate - still pertinent or useless? Controversy 5: Should Digoxin be still considerted in HF managemant Dr Rajashekharan Memorial Lecture Economics of transplant and advanced HF in India

5 Mechanical Cardiac Support ECMO support for PCI LVAD - Where do we stand now? Is IABP still a choice for Cardiogenic shock Subclavian IABP: An excellent bridge to transplantation Total artificial heart Indigenous LVAD -a novel substitute Medical Heart failure Day 2: 16th Sept 2018 (Sunday) HFpEF: Controversies, challenges and future directions Atrial fibrillation in Heart Failure : the best strategy Approach to tackle anemia and fraility in Heart failure Prevention of re-admission in heart failure patients - A quest incompletely fullfilled. Predicting "Super-response" with CRT in LBBB patients My Unforgettable / most memorable cases in HF Lung Transplantation LT: Selection and management to success Lung Allograft preservation Technique of Lung Transplant Lung transplant after prior cardiac surgery Lung Transplant: India presents Heart and Lung Transplant: Challenges Problem solving in Heart failure Left Ventricular Ejection Fraction. What is normal? Worsening renal function on ARNI Hyperkalemia in Chronic HF. How can I continue Renin angiotensin inhibitors? Surgical Management of RV Failure Recurrent VT after Primary angioplasty in Myocardial infarction Hyponatremia in Acute Heart Failure. Patient in pulmonary edema. Free Paper Award Session

6 WORKSHOPS BREAKFAST SESSION 16 th Sept to 0830 hrs Complex case scenarios in Transplantation ( Registration free : Limited to 50 ) PANELISTS : Dr Richard Daly Dr Catherine Sudarshan Dr Jai S.Raman PRESENTERS : Dr Milind Hote Dr Sandeep Attawar Dr Manoj Durairaj Dr Anway Mulay WORKSHOP on ECMO 15th Sept hrs ( Supported by GETINGE ) Restricted to 25 registrations Registration fee : Rs.1000 /- Course Coordinator : Dr Paul Ramesh Mr PVS Prakash WORKSHOP on VAD 16th Sept hrs ( Supported by ABBOTT ) Restricted to 25 registrations Registration fee : Rs.1000 /- WORKSHOP on CARDIAC PATHOLOGY 16th Sept hrs Conducted by: Dr.Rajendiran Professor of Pathology, Ramachandra Institute of Medical Sciences Course Coordinator: No Registration fee Dr.A.Radha Chief Pathologist, GKNM Hospital, Coimbatore Lunch Symposium : 'How to setup a heart failure clinic' 15th Sept hrs ( Supported by CIPLA ) CRT Workshop : 16th Sept hrs ( Supported by ABBOTT ) Conducted by: Registration of HEART TEAMS by Invitation only Course Coordinator: Dr.Ramprakash Restricted to 25 registrations No Registration fee Dr.Sandeep Seth Professor of Cardiology, All India Institute of Medical Sciences, New Delhi

7 REGISTRATION Date Before 15 th August After 15 th August ACCOMODATION Account Name: SFHFT CON 2018 Account No: IFSC Code: FDRL Bank: Federal bank Branch: Coimbatore, Pappanaickenpalayam Hotel Name Room Type Single Occupancy Double Occupancy Residency Taj Radisson Blu ITC Zone Grand Regent IBIS Members 3000/- Deluxe Superior Charm Standard Deluxe Zone Regal Standard Queen Non-Members Students 5000/- 1000/- 4000/- 6000/- 1500/ / / / / / / / / / / / / / /- Rates mentioned are for one night inclusive of breakfast ++ Taxes extra For accomodation booking contact : Mr. Rajesh, rajeshswk@gmail.com, TRAVEL For travel details contact : Mr. Kumar ( Essvee Travels ), , kumarstarline@gmail.com, ORGANISING COMMITTEE Chief Patron: Dr Ragupathy Veluswamy Patrons: Secretary: Members: Dr S Muralidharan Dr J K Periaswamy Dr S Natarajan Dr P Chandrasekar Dr Rajpal K Abhaichand Dr Sundar Ramanathan Dr Balaji Dr P R Vaidhyanathan Dr Vijayakumar Raju Dr Thiagaraja Murthy Dr K A Sambasivam Dr Madhava Rao Dr Chockalingam Dr Ramprakash Dr Prashanth Vaijayanath Dr Thomas Alexander Dr Chakravarthi Dr Murugesan Dr Jnanesh Thacker Dr Bivin Wilson Dr Y Y Rao Dr Aayush Poddar Dr M Kalyanasundaram Dr G Rajendran Dr Tamashis Mukherjee Organising Secretary: Dr P Chandrasekar Chief, Division of Cardiac Surgery Director, Cardiac Transplantation GKNM Hospital, Coimbatore sfhftcon2018@gmail.com

The Residency Towers. 15 th - 16 th September. Coimbatore, Tamilnadu. 6 th Annual Conference Society for Heart Failure and Transplantation

The Residency Towers. 15 th - 16 th September. Coimbatore, Tamilnadu. 6 th Annual Conference Society for Heart Failure and Transplantation Endorsed by the International Society for Heart and Lung Transplantation 6 th Annual Conference Society for Heart Failure and Transplantation The Residency Towers Coimbatore, Tamilnadu Register Now!!!

More information

28th Annual Conference of Indian Society of Organ Transplantation. 13th-15th Oct, 2017 Brilliant Convention Center, Indore.

28th Annual Conference of Indian Society of Organ Transplantation. 13th-15th Oct, 2017 Brilliant Convention Center, Indore. 28th Annual Conference of Indian Society of Organ Transplantation 13th-15th Oct, 2017 Brilliant Convention Center, Indore www.isot2017.com Heart Lung 13th October 2017, Indore Convener: Dr. Kewal Krishan

More information

SfHFTCON2019 a comprehensive 'A to Z' symposium on 'HEART FAILURE & TRANSPLANTATION'

SfHFTCON2019 a comprehensive 'A to Z' symposium on 'HEART FAILURE & TRANSPLANTATION' SfHFTCON2019 a comprehensive 'A to Z' symposium on 'HEART FAILURE & TRANSPLANTATION' 23rd - 25th August 2019 Hotel Grand Hyatt, Mumbai rd CME Day, 23 August 2019 Who Should Attend? Cardiologists, Internists,

More information

SfHFT2019 A comprehensive 'A to Z' symposium on 'HEART FAILURE & TRANSPLANTATION'

SfHFT2019 A comprehensive 'A to Z' symposium on 'HEART FAILURE & TRANSPLANTATION' SfHFT2019 A comprehensive 'A to Z' symposium on 'HEART FAILURE & TRANSPLANTATION' 23rd - 25 August 2019 Hotel Grand Hyatt, Mumbai rd CME Day, 23 August 2019 Who Should Attend? Cardiologists, Internists,

More information

DISCLOSURES ACHIEVING SUCCESS THROUGH FAILURE: UPDATE ON HEART FAILURE WITH PRESERVED EJECTION FRACTION NONE

DISCLOSURES ACHIEVING SUCCESS THROUGH FAILURE: UPDATE ON HEART FAILURE WITH PRESERVED EJECTION FRACTION NONE ACHIEVING SUCCESS THROUGH FAILURE: UPDATE ON HEART FAILURE WITH PRESERVED EJECTION FRACTION Lori M. Tam, MD Providence Heart Institute DISCLOSURES NONE 1 OUTLINE Systolic vs. Diastolic Heart Failure New

More information

State-of-the-Art Management of Chronic Systolic Heart Failure

State-of-the-Art Management of Chronic Systolic Heart Failure State-of-the-Art Management of Chronic Systolic Heart Failure Michael McCulloch, MD 17 th Annual Cardiovascular Update Intermountain Medical Center December 16, 2017 Disclosures: I have no financial disclosures

More information

The ACC Heart Failure Guidelines

The ACC Heart Failure Guidelines The ACC Heart Failure Guidelines Fakhr Alayoubi, Msc,R Ph President of SCCP Cardiology Clinical Pharmacist Assistant Professor At King Saud University King Khalid University Hospital Riyadh-KSA 2017 ACC/AHA/HFSA

More information

Dr. Tennyson S. Dr. Sivasankaran S. Dr. A. K. Abraham Dr. Jabir A.

Dr. Tennyson S. Dr. Sivasankaran S. Dr. A. K. Abraham Dr. Jabir A. Dear Colleague, It is our pleasure to invite you to Cochin for the summer conference of CSI Kerala Chapter 2013. The conference starts with the workshop on May 4 th and we have the main scientific sessions

More information

The 54th Annual Meeting of The Society of Thoracic

The 54th Annual Meeting of The Society of Thoracic THE SOCIETY OF THORACIC SURGEONS: FIFTY-FOURTH ANNUAL MEETING The Society of Thoracic Surgeons 54th Annual Meeting January 27 31, 2018 Greater Fort Lauderdale/Broward County Convention Center, Fort Lauderdale,

More information

Disclosures. Advances in Chronic Heart Failure Management 6/12/2017. Van N Selby, MD UCSF Advanced Heart Failure Program June 19, 2017

Disclosures. Advances in Chronic Heart Failure Management 6/12/2017. Van N Selby, MD UCSF Advanced Heart Failure Program June 19, 2017 Advances in Chronic Heart Failure Management Van N Selby, MD UCSF Advanced Heart Failure Program June 19, 2017 I have nothing to disclose Disclosures 1 Goal statement To review recently-approved therapies

More information

What s new in 2016 Guidelines of the European Society of Cardiology? HEART FAILURE. Marc Ferrini (Lyon Fr)

What s new in 2016 Guidelines of the European Society of Cardiology? HEART FAILURE. Marc Ferrini (Lyon Fr) What s new in 2016 Guidelines of the European Society of Cardiology? HEART FAILURE Marc Ferrini (Lyon Fr) Palermo (I) 1 04 2017 Consulting Fees, Honoraria: BAYER PHARMA BOEHRINGER INGELHEIM BRISTOL MEYERS

More information

ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure

ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure Patients t with acute heart failure frequently develop chronic heart failure Patients with chronic heart failure frequently decompensate acutely ESC Guidelines for the Diagnosis and A clinical response

More information

Heart Failure Medical and Surgical Treatment

Heart Failure Medical and Surgical Treatment Heart Failure Medical and Surgical Treatment Daniel S. Yip, M.D. Medical Director, Heart Failure and Transplantation Mayo Clinic Second Annual Lakeland Regional Health Cardiovascular Symposium February

More information

Cardiopulmonary Rehabilitation

Cardiopulmonary Rehabilitation ST 1 NATIONAL CONFERENCE ON Cardiopulmonary Rehabilitation 23 & 24 September 2017 Senate Hall, The Tamilnadu Dr. MGR Medical University, Chennai Host Cardiac Wellness Institute, Chennai. Co-host The Tamilnadu

More information

PCHF A NOVEL COURSE IN HEART FAILURE MANAGEMENT POSTGRADUATE COURSE IN HEART FAILURE LONDON. January 2019 to October 2020

PCHF A NOVEL COURSE IN HEART FAILURE MANAGEMENT POSTGRADUATE COURSE IN HEART FAILURE LONDON. January 2019 to October 2020 PCHF POSTGRADUATE COURSE IN HEART FAILURE LONDON A NOVEL COURSE IN HEART FAILURE MANAGEMENT January 2019 to October 2020 Venue: The Royal Society of Medicine, 1 Wimpole Street, Marylebone, London, UK Endorsed

More information

Heart Failure: Guideline-Directed Management and Therapy

Heart Failure: Guideline-Directed Management and Therapy Heart Failure: Guideline-Directed Management and Therapy Guideline-Directed Management and Therapy (GDMT) was developed by the American College of Cardiology and American Heart Association to define the

More information

WHAT S NEW IN HEART FAILURE

WHAT S NEW IN HEART FAILURE WHAT S NEW IN HEART FAILURE Drugs, Devices and Diagnostics John M. Herre, MD, FACC, FACP Director, Advanced Heart Failure Program Sentara Helathcare Professor of Medicine Eastern Virginia Medical School

More information

Disclosures. Overview. Goal statement. Advances in Chronic Heart Failure Management 5/22/17

Disclosures. Overview. Goal statement. Advances in Chronic Heart Failure Management 5/22/17 Disclosures Advances in Chronic Heart Failure Management I have nothing to disclose Van N Selby, MD UCSF Advanced Heart Failure Program May 22, 2017 Goal statement To review recently-approved therapies

More information

Heart Failure Therapies State of the Art 2017

Heart Failure Therapies State of the Art 2017 Heart Failure Therapies State of the Art 2017 Andrew J. Sauer, MD Assistant Professor Director, Center for Heart Failure Medical Director, Heart Transplantation UNOS Primary Transplant Physician asauer@kumc.edu

More information

Program Schedule Cardiology Update in Sedona: The Heart of the Matter

Program Schedule Cardiology Update in Sedona: The Heart of the Matter Thursday, August 3, 2017 Program Schedule Cardiology Update in Sedona: The Heart of the Matter Noon Registration and Exhibits 1:50 p.m. Welcome Announcements SESSION 1 MODERATORS: Luis R. Scott, M.D and

More information

16/12/14. Dear Colleagues

16/12/14. Dear Colleagues 16/12/14 Dear Colleagues The fifth Indo-Singapore conference: ISCON 2015 is proposed to be held on the 14 th and 15 th February, 2015. This year the focus would be on Head and Neck cancers. It is also

More information

VIENNA HEART M AY FAILURE ADVANCE PROGRAMME. World Congress on Acute Heart Failure. Organised by the Heart Failure Association of the ESC

VIENNA HEART M AY FAILURE ADVANCE PROGRAMME. World Congress on Acute Heart Failure. Organised by the Heart Failure Association of the ESC Organised by the Heart Failure Association of the ESC HEART 2018 FAILURE including the 2 6-2 9 M AY VIENNA ADVANCE PROGRAMME www.escardio.org/heartfailure WELCOME Heart Failure is the world s leading congress

More information

CLINICAL PRACTICE GUIDELINE

CLINICAL PRACTICE GUIDELINE CLINICAL PRACTICE GUIDELINE Procedure: Congestive Heart Failure Guideline Review Cycle: Biennial Reviewed By: Amish Purohit, MD, MHA, CPE, FACHE Review Date: November 2014 Committee Approval Date: 11/12/2014

More information

Heart Failure 101 The Basic Principles of Diagnosis & Management

Heart Failure 101 The Basic Principles of Diagnosis & Management Heart Failure 101 The Basic Principles of Diagnosis & Management Bill Tran, MD Non Invasive Cardiologist February 24, 2018 What the eye does not see and the mind does not know, does not exist. DH Lawrence

More information

Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes

Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes Seung-Jae Joo and other KAMIR-NIH investigators Department of Cardiology, Jeju National

More information

Initiating New Medications in the Management of Heart Failure

Initiating New Medications in the Management of Heart Failure Initiating New Medications in the Management of Heart Failure Sandra Oliver-McNeil DNP, MSN, ACNP-BC, CHFN Associate Professor (Clinical) Wayne State University College of Nursing Objectives The participant

More information

HEART FAILURE. Study day November 2017 Sarah Briggs and Janet Laing

HEART FAILURE. Study day November 2017 Sarah Briggs and Janet Laing HEART FAILURE Study day November 2017 Sarah Briggs and Janet Laing Overview and Introduction This course is an introduction and overview of heart failure. Normal heart function and basic pathophysiology

More information

Bermuda Anesthesia Summer Symposium 2012 (BASS) August 29- September 1, 2012

Bermuda Anesthesia Summer Symposium 2012 (BASS) August 29- September 1, 2012 Bermuda Anesthesia Summer Symposium 2012 (BASS) August 29- September 1, 2012 Fairmont Southampton, Bermuda Resort Hosted by: The University of Pittsburgh Department of Anesthesiology Fifteen CME credits

More information

Congestive Heart Failure: Outpatient Management

Congestive Heart Failure: Outpatient Management The Chattanooga Heart Institute Cardiovascular Symposium Congestive Heart Failure: Outpatient Management E. Philip Lehman MD, MPP Disclosure No financial disclosures. Objectives Evidence-based therapy

More information

Beyond ACE-inhibitors for Heart Failure. Jacob Townsend, MD NCVH Birmingham 2015

Beyond ACE-inhibitors for Heart Failure. Jacob Townsend, MD NCVH Birmingham 2015 Beyond ACE-inhibitors for Heart Failure Jacob Townsend, MD NCVH Birmingham 2015 % Decrease in Mortality Current Therapy HFrEF 0% Angiotensin receptor blocker ACE inhibitor Beta blocker Mineralocorticoid

More information

INNOVATIONS MS ADVANCED IN HEART FAILURE THURSDAY, OCTOBER 11, 2018 NEW YORK ACADEMY OF MEDICINE, NEW YORK, NY DIRECTORS

INNOVATIONS MS ADVANCED IN HEART FAILURE THURSDAY, OCTOBER 11, 2018 NEW YORK ACADEMY OF MEDICINE, NEW YORK, NY DIRECTORS 3rd Annual MS ADVANCED INNOVATIONS IN HEART FAILURE Cases, Controversies and State-of-the-Art Update in Heart Failure and Advanced Cardiac Care THURSDAY, OCTOBER 11, 2018 NEW YORK ACADEMY OF MEDICINE,

More information

Integrating Devices. Pharmacotherapy

Integrating Devices. Pharmacotherapy Fifth Annual New Frontiers in Heart Failure Therapy Integrating Devices & Pharmacotherapy Saturday, January 22, 2005 7:30AM 5:00PM 301 Park Avenue at East 49th Street New York, NY Jointly Sponsored by

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

Heart Failure Management. Waleed AlHabeeb, MD, MHA Assistant Professor of Medicine Consultant Heart Failure Cardiologist

Heart Failure Management. Waleed AlHabeeb, MD, MHA Assistant Professor of Medicine Consultant Heart Failure Cardiologist Heart Failure Management Waleed AlHabeeb, MD, MHA Assistant Professor of Medicine Consultant Heart Failure Cardiologist Heart failure prevalence is expected to continue to increase¹ 21 MILLION ADULTS WORLDWIDE

More information

Management Strategies for Advanced Heart Failure

Management Strategies for Advanced Heart Failure Management Strategies for Advanced Heart Failure Mary Norine Walsh, MD, FACC Medical Director, HF and Cardiac Transplantation St Vincent Heart Indianapolis, IN USA President American College of Cardiology

More information

Advanced Heart Failure and Transplant Cardiology

Advanced Heart Failure and Transplant Cardiology Advanced Heart Failure and Transplant Cardiology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills

More information

1/4/18. Heart Failure Guideline Review and Update. Disclosure. Pharmacist Objectives. Pharmacy Technician Objectives. What is Heart Failure?

1/4/18. Heart Failure Guideline Review and Update. Disclosure. Pharmacist Objectives. Pharmacy Technician Objectives. What is Heart Failure? Disclosure Heart Failure Guideline Review and Update I have had no financial relationship over the past 12 months with any commercial sponsor with a vested interest in this presentation. Natalie Beiter,

More information

The Pathophysiology of Cardiogenic Shock Knowledge Gaps & Opportunities

The Pathophysiology of Cardiogenic Shock Knowledge Gaps & Opportunities The Pathophysiology of Cardiogenic Shock Knowledge Gaps & Opportunities Navin K. Kapur, MD, FACC, FSCAI, FAHA Associate Professor, Department of Medicine Interventional Cardiology & Advanced Heart Failure

More information

Heart Failure with Reduced EF. Dino Recchia, MD, FACC, FHFSA

Heart Failure with Reduced EF. Dino Recchia, MD, FACC, FHFSA Heart Failure with Reduced EF Dino Recchia, MD, FACC, FHFSA Heart Failure HF is the end phenotype of almost all CV disorders Complex clinical syndrome resulting from any structural or functional impairment

More information

Case - Advanced HF and Shock (INTERMACS 1)

Case - Advanced HF and Shock (INTERMACS 1) Case - Advanced HF and Shock (INTERMACS 1) Navin K. Kapur, MD, FACC, FSCAI, FAHA Associate Professor, Department of Medicine Interventional Cardiology & Advanced Heart Failure Programs Executive Director,

More information

NICE Chronic Heart Failure Guidelines in Adults 2018

NICE Chronic Heart Failure Guidelines in Adults 2018 NICE Chronic Heart Failure Guidelines in Adults 2018 The Whys, Whats and Hows of the importance of effectively managing heart failure in Primary Care and the community. Foreword Dr Clare J Taylor, General

More information

Remote management of heart failure using implanted devices and formalized follow-up procedures (REM-HF)

Remote management of heart failure using implanted devices and formalized follow-up procedures (REM-HF) Remote management of heart failure using implanted devices and formalized follow-up procedures (REM-HF) Martin R Cowie Professor of Cardiology, Imperial College London (Royal Brompton Hospital) London,

More information

The CCS Heart Failure Companion: Bridging Guidelines to your Practice

The CCS Heart Failure Companion: Bridging Guidelines to your Practice The CCS Heart Failure Companion: Bridging Guidelines to your Practice Looking for practical answers concerning optimal heart failure care? The CCS Heart Failure Guidelines Companion can help. The Canadian

More information

Performance and Quality Measures 1. NQF Measure Number. Coronary Artery Disease Measure Set

Performance and Quality Measures 1. NQF Measure Number. Coronary Artery Disease Measure Set Unless indicated, the PINNACLE Registry measures are endorsed by the American College of Cardiology Foundation and the American Heart Association and may be used for purposes of health care insurance payer

More information

Jeffrey A. Morgan, MD Professor and Chief Division of Cardiothoracic Transplant and MCS Texas Heart Institute Baylor College of Medicine

Jeffrey A. Morgan, MD Professor and Chief Division of Cardiothoracic Transplant and MCS Texas Heart Institute Baylor College of Medicine Jeffrey A. Morgan, MD Professor and Chief Division of Cardiothoracic Transplant and MCS Joseph S. Coselli, MD Professor and Vice Chair Department of Surgery Chief, Adult Cardiac Surgery at Baylor St. Luke

More information

UPDATES IN MANAGEMENT OF HF

UPDATES IN MANAGEMENT OF HF UPDATES IN MANAGEMENT OF HF Jennifer R Brown MD, MS Heart Failure Specialist Medstar Cardiology Associates DC ACP Meeting Fall 2017 Disclosures: speaker bureau for novartis speaker bureau for actelion

More information

Satish K Surabhi, MD.FACC,FSCAI,RPVI Medical Director, Cardiac Cath Labs AnMed Health Heart & Vascular Care

Satish K Surabhi, MD.FACC,FSCAI,RPVI Medical Director, Cardiac Cath Labs AnMed Health Heart & Vascular Care Satish K Surabhi, MD.FACC,FSCAI,RPVI Medical Director, Cardiac Cath Labs AnMed Health Heart & Vascular Care None Fig. 1. Progression of Heart Failure.With each hospitalization for acute heart failure,

More information

NCAP NATIONAL CARDIAC AUDIT PROGR AMME NATIONAL HEART FAILURE AUDIT 2016/17 SUMMARY REPORT

NCAP NATIONAL CARDIAC AUDIT PROGR AMME NATIONAL HEART FAILURE AUDIT 2016/17 SUMMARY REPORT NCAP NATIONAL CARDIAC AUDIT PROGR AMME NATIONAL HEART FAILURE AUDIT 2016/17 SUMMARY REPORT CONTENTS PATIENTS ADMITTED WITH HEART FAILURE...4 Demographics... 4 Trends in Symptoms... 4 Causes and Comorbidities

More information

Heart Failure Update. Bibiana Cujec MD May 2015

Heart Failure Update. Bibiana Cujec MD May 2015 Heart Failure Update Bibiana Cujec MD May 2015 Disclosures Participation in clinical trial GUIDE IT (BNP in management of HF) Plan Review of new trials/ccs guidelines Management of heart failure: cases

More information

HF/HTX. Tuesday, April 10, 2018 MEDITERRANEE ABC. In HEART FAILURE AND CARDIAC TRANSPLANTATION. Scientific Program Committee.

HF/HTX. Tuesday, April 10, 2018 MEDITERRANEE ABC. In HEART FAILURE AND CARDIAC TRANSPLANTATION. Scientific Program Committee. ISHLT ACADEMY In HEART FAILURE AND CARDIAC TRANSPLANTATION Tuesday, April 10, 2018 MEDITERRANEE ABC 7:55 am 5:30 PM Scientific Program Committee CHAIR: Shelley Hall, MD, Baylor University CO-CHAIR: Lavanya

More information

Symposium on Gastrointestinal Pathology

Symposium on Gastrointestinal Pathology SRL Global Knowledge Forum Presents Symposium on Gastrointestinal Pathology Sunday, 7 th September, 2014 Venue: Exhibition Cum Convention Centre, Sector 12, Faridabad, Haryana Organised By: Department

More information

Management of chronic heart failure: pharmacology. Giuseppe M.C. Rosano, MD, PhD, FHFA

Management of chronic heart failure: pharmacology. Giuseppe M.C. Rosano, MD, PhD, FHFA Management of chronic heart failure: pharmacology. Giuseppe M.C. Rosano, MD, PhD, FHFA Declaration of potential conflict of interests Type of job or financial support Salary Ordinary funds Position in

More information

Diagnosis and management of Chronic Heart Failure in 2018: What does NICE say? PCCS Meeting Issues and Answers Conference Nottingham

Diagnosis and management of Chronic Heart Failure in 2018: What does NICE say? PCCS Meeting Issues and Answers Conference Nottingham Diagnosis and management of Chronic Heart Failure in 2018: What does NICE say? PCCS Meeting Issues and Answers Conference Nottingham NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Chronic heart failure

More information

LCZ696 A First-in-Class Angiotensin Receptor Neprilysin Inhibitor

LCZ696 A First-in-Class Angiotensin Receptor Neprilysin Inhibitor The Angiotensin Receptor Neprilysin Inhibitor LCZ696 in Heart Failure with Preserved Ejection Fraction The Prospective comparison of ARNI with ARB on Management Of heart failure with preserved ejection

More information

INDIAN SOCIETY FOR CLINICAL RESEARCH 11th Annual ISCR Conference Collaborative Clinical Research for better Patient outcomes January, 2018

INDIAN SOCIETY FOR CLINICAL RESEARCH 11th Annual ISCR Conference Collaborative Clinical Research for better Patient outcomes January, 2018 Agenda: Friday, 19th January 2018 07:30-17:00. INDIAN SOCIETY FOR CLINICAL RESEARCH 11th Annual ISCR Conference Collaborative Clinical Research for better Patient outcomes 19-20 January, 2018 Hotel J.

More information

XIV NATIONAL WORKSHOP ON TOXICOLOGIC PATHOLOGY

XIV NATIONAL WORKSHOP ON TOXICOLOGIC PATHOLOGY Society of Toxicologic Pathology-India - STP-I Indian Board of Toxicologic Pathology - IBTP (affiliate of Society of Toxicologic Pathology-India) The Grand Solitaire, Secunderabad 7th and 8th October 2017

More information

TEACH & TREAT Post-Myocardial Infarction Left Ventricular Systolic Dysfunction

TEACH & TREAT Post-Myocardial Infarction Left Ventricular Systolic Dysfunction TEACH & TREAT Post-Myocardial Infarction Left Ventricular Systolic Dysfunction Clare Murphy, Paul Forsyth, Steve McGlynn, Margaret Ryan, Anne Watson, Lynsey Moir, Iain Speirits, Mark Petrie, Ninian Lang,

More information

2/3/2017. Objectives. Effective Heart Failure Management through Evidence Based Practice and Innovation

2/3/2017. Objectives. Effective Heart Failure Management through Evidence Based Practice and Innovation Effective Heart Failure Management through Evidence Based Practice and Innovation Jennifer Bauerly RN, CHFN, APRN-BC CentraCare Heart and Vascular Center Objectives Describe the scope and impact of heart

More information

Introduction to Heart Failure. Mauricio Velez, M.D. Transplant Cardiologist APACVS 2018 April 5-7 Miami, FL

Introduction to Heart Failure. Mauricio Velez, M.D. Transplant Cardiologist APACVS 2018 April 5-7 Miami, FL Introduction to Heart Failure Mauricio Velez, M.D. Transplant Cardiologist APACVS 2018 April 5-7 Miami, FL Disclosures No relevant financial relationships to disclose Objectives and Outline Define heart

More information

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure Developed in Collaboration With the American Academy of Family Physicians, American College of Chest

More information

Heart Failure: Combination Treatment Strategies

Heart Failure: Combination Treatment Strategies Heart Failure: Combination Treatment Strategies M. McDonald MD, FRCP State of the Heart Symposium May 28, 2011 None Disclosures Case 69 F, prior MIs (LV ejection fraction 25%), HTN No demonstrable ischemia

More information

HEART FAILURE. Study day November 2018 Sarah Briggs

HEART FAILURE. Study day November 2018 Sarah Briggs HEART FAILURE Study day November 2018 Sarah Briggs Overview and Introduction This course is an introduction and overview of heart failure. Normal heart function and basic pathophysiology of heart failure

More information

Saudi Heart Failure Guidelines. Waleed AlHabeeb, MD, MHA Consultant Heart Failure Cardiologist President of the Saudi Heart Failure Group

Saudi Heart Failure Guidelines. Waleed AlHabeeb, MD, MHA Consultant Heart Failure Cardiologist President of the Saudi Heart Failure Group Saudi Heart Failure Guidelines Waleed AlHabeeb, MD, MHA Consultant Heart Failure Cardiologist President of the Saudi Heart Failure Group Heart Failure Expert committee The Heart Failure Expert Committee,

More information

Target dose achievement of evidencebased medications in patients with heart failure with reduced ejection fraction attending a heart failure clinic

Target dose achievement of evidencebased medications in patients with heart failure with reduced ejection fraction attending a heart failure clinic Target dose achievement of evidencebased medications in patients with heart failure with reduced ejection fraction attending a heart failure clinic June Chen 1, Charlotte Galenza 1, Justin Ezekowitz 2,3,

More information

Program Director: Neala J. Hunter, MD, FACC

Program Director: Neala J. Hunter, MD, FACC Jeffrey M. Carlton Heart & Vascular Institute Presents ADVANCES IN ARRHYTHMIA MANAGEMENT Program Director: Neala J. Hunter, MD, FACC This program is made possible by a generous donation to the Foundation

More information

PRESS RELEASE. New NICE guidance will improve diagnosis and treatment of chronic heart failure

PRESS RELEASE. New NICE guidance will improve diagnosis and treatment of chronic heart failure Tel: 0845 003 7782 www.nice.org.uk Ref: 2010/118 ISSUED: WEDNESDAY, 25 AUGUST 2010 PRESS RELEASE New NICE guidance will improve diagnosis and treatment of chronic heart failure The National Institute for

More information

ASSOCIATION OF PHYSICIANS OF INDIA. Annual Day Celebration & Scientific Meet. Theme Newer Trends in Internal Medicine

ASSOCIATION OF PHYSICIANS OF INDIA. Annual Day Celebration & Scientific Meet. Theme Newer Trends in Internal Medicine ASSOCIATION OF PHYSICIANS OF INDIA CHENNAI CHAPTER Annual Day Celebration & Scientific Meet Theme Newer Trends in Internal Medicine Saturday 17 th & Sunday 18 th August 2013 @ Hotel Savera Dr.Radhakrishnan

More information

Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with HeartMate 3 (MOMENTUM 3) Long Term Outcomes

Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with HeartMate 3 (MOMENTUM 3) Long Term Outcomes Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with (MOMENTUM 3) Long Term Outcomes Mandeep R. Mehra, MD, Daniel J. Goldstein, MD, Nir Uriel, MD, Joseph

More information

Advanced Congenital Cardiac Morphology

Advanced Congenital Cardiac Morphology Advanced Congenital Cardiac Morphology October 18 22, 2015 Ruth and Tristram Colket, Jr. Translational Research Building at The Children s Hospital of Philadelphia Philadelphia, Pa. www.chop.edu/cme Program:

More information

Percutaneous Mechanical Circulatory Support Devices

Percutaneous Mechanical Circulatory Support Devices Percutaneous Mechanical Circulatory Support Devices Daniel Vazquez RN, RCIS Miami Cardiac & Vascular Institute FINANCIAL DISCLOSURES none CASE STUDY CASE STUDY 52 year old gentlemen Complaining of dyspnea

More information

Gerasimos Filippatos MD, FESC, FCCP, FACC

Gerasimos Filippatos MD, FESC, FCCP, FACC Gerasimos Filippatos MD, FESC, FCCP, FACC Head of HF Unit at Athens University Hospital, Greece President (2014-2016) of the HF Association of the European Society of Cardiology (ESC) Served as Chair of

More information

INVITING ALL CONSULTANTS AND TRAINEES THIRTEEN INTERNATIONAL AND FOUR NATIONAL FACULTY FREE BUT MANADATORY REGISTRATION FOR CMC STAFF AND STUDENTS

INVITING ALL CONSULTANTS AND TRAINEES THIRTEEN INTERNATIONAL AND FOUR NATIONAL FACULTY FREE BUT MANADATORY REGISTRATION FOR CMC STAFF AND STUDENTS Greetings from the organizing team! Christi crux est mea lux soli Deo honor et gloria! INVITING ALL CONSULTANTS AND TRAINEES THIRTEEN INTERNATIONAL AND FOUR NATIONAL FACULTY FREE BUT MANADATORY REGISTRATION

More information

Innovation therapy in Heart Failure

Innovation therapy in Heart Failure Innovation therapy in Heart Failure P. Laothavorn September 2015 Topics of discussion Basic Knowledge about heart failure Standard therapy New emerging therapy References: standard Therapy in Heart Failure

More information

Advanced Congenital Cardiac Morphology

Advanced Congenital Cardiac Morphology Advanced Congenital Cardiac Morphology October 30 to November 3, 2016 Ruth and Tristram Colket, Jr. Translational Research Building at The Children s Hospital of Philadelphia Philadelphia, Pa. www.chop.edu/cme

More information

Association between RV Function in PPCM and LV Recovery & Clinical Outcome

Association between RV Function in PPCM and LV Recovery & Clinical Outcome Association between RV Function in PPCM and LV Recovery & Clinical Outcome Lori A Blauwet, MD, MA Associate Professor of Medicine Co-Director, Cardio-OB Clinic Mayo Clinic Rochester, MN USA 2016 MFMER

More information

New NICE Heart Failure Guidelines What do they mean for primary and secondary care, and patients?

New NICE Heart Failure Guidelines What do they mean for primary and secondary care, and patients? New NICE Heart Failure Guidelines 2018 - What do they mean for primary and secondary care, and patients? Prof Ahmet Fuat PhD FRCGP FRCP PG Dip (Cardiology) GP & GPSI Cardiology Darlington Professor of

More information

Heart Failure. Subjective SOB (shortness of breath) Peripheral edema. Orthopnea (2-3 pillows) PND (paroxysmal nocturnal dyspnea)

Heart Failure. Subjective SOB (shortness of breath) Peripheral edema. Orthopnea (2-3 pillows) PND (paroxysmal nocturnal dyspnea) Pharmacology I. Definitions A. Heart Failure (HF) Heart Failure Ezra Levy, Pharm.D. HF Results when one or both ventricles are unable to pump sufficient blood to meet the body s needs There are 2 types

More information

Cardio-Vascular Pathology. Update and 12 March Venue : Seminar Hall, 3"* floor. AMC Block, SCTIMST. Organized by

Cardio-Vascular Pathology. Update and 12 March Venue : Seminar Hall, 3* floor. AMC Block, SCTIMST. Organized by Cardio-Vascular Pathology Update 2018 11 and 12 March 2018 Venue : Seminar Hall, 3"* floor AMC Block, SCTIMST Organized by Department of Pathology Sree Chitra TIrunal Institute for Medical Sciences ^Technology

More information

Disclosures for Presenter

Disclosures for Presenter A Comparison of Angiotensin Receptor- Neprilysin Inhibition (ARNI) With ACE Inhibition in the Long-Term Treatment of Chronic Heart Failure With a Reduced Ejection Fraction Milton Packer, John J.V. McMurray,

More information

Advanced Congenital Cardiac Morphology

Advanced Congenital Cardiac Morphology Advanced Congenital Cardiac Morphology October 19 23, 2014 Ruth and Tristram Colket, Jr. Translational Research Building at Philadelphia, Pa. www.chop.edu/cme Program: Oct. 19 23, 2014 Sunday, Oct. 19

More information

Advanced Congenital Cardiac Morphology. Sunday, Oct. 22, to Thursday, Oct. 26, Learn more: chop.cloud-cme.com

Advanced Congenital Cardiac Morphology. Sunday, Oct. 22, to Thursday, Oct. 26, Learn more: chop.cloud-cme.com Advanced Congenital Cardiac Morphology Sunday, Oct. 22, to Thursday, Oct. 26, 2017 Ruth and Tristram Colket, Jr. Translational Research Building Learn more: chop.cloud-cme.com 1 Course Information Course

More information

A patient with decompensated HF

A patient with decompensated HF A patient with decompensated HF Professor Michel KOMAJDA University Pierre & Marie Curie Pitie Salpetriere Hospital Department of Cardiology Paris (France) Declaration Of Interest 2010 Speaker : Servier,

More information

Public Health Foundation of India DIABETES UPDATE 2014, KOLKATA (West Bengal)

Public Health Foundation of India DIABETES UPDATE 2014, KOLKATA (West Bengal) Public Health Foundation of India DIABETES UPDATE 2014, KOLKATA (West Bengal) Dr. Sandeep Bhalla (Program Director CCEBDM, CCGDM, ACMDC) addressing the audience at Diabetes Update 2014, Kolkata (West Bengal)

More information

October 1 and 2, 2010

October 1 and 2, 2010 Nonprofit Org. U.S. Postage PAID Pittsburgh, PA Permit No. 2110 D E P A R T M E N T O F C A R D I O T H O R A C I C S U R G E R Y : Surgical Treatment of End-Stage Cardiopulmonary Diseases October 1 and

More information

Guideline-Directed Medical Therapy

Guideline-Directed Medical Therapy Guideline-Directed Medical Therapy Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation OPTIMAL THERAPY (As defined in

More information

5 th PVRI Annual Drug Discovery & Development Symposium for Pulmonary Hypertension. The pathway to breakthrough therapies WELCOME TO BETHESDA

5 th PVRI Annual Drug Discovery & Development Symposium for Pulmonary Hypertension. The pathway to breakthrough therapies WELCOME TO BETHESDA Insights from leaders in academia, industry & regulatory... Promising targets ready for clinical development... PVRI Innovative drug discovery for faster approval... Pulmonary vascular diseases... Right

More information

Chronic. Outline. Congestive^ Heart Failure: Update on Effective Monitoring and Treatment. Heart Failure Epidemiology. Michael G.

Chronic. Outline. Congestive^ Heart Failure: Update on Effective Monitoring and Treatment. Heart Failure Epidemiology. Michael G. Chronic Congestive^ Heart Failure: Update on Effective Monitoring and Treatment Michael G. Shlipak, MD, MPH Professor of Medicine, UCSF Chief, Division of General Internal Medicine, SFVA Medical Center

More information

The Author(s) This article is published with open access by ASEAN Federation of Cardiology

The Author(s) This article is published with open access by ASEAN Federation of Cardiology DOI 10.7603/s40602-014-0011-3 ASEAN Heart Journal http://www.aseanheartjournal.org/ Vol. 22, no. 1, 60 65 (2014) ISSN: 2315-4551 Erratum Erratum to: Impact Of Sex On Clinical Characteristics And In-Hospital

More information

Neprilysin Inhibitor (Entresto ) Prior Authorization and Quantity Limit Program Summary

Neprilysin Inhibitor (Entresto ) Prior Authorization and Quantity Limit Program Summary Neprilysin Inhibitor (Entresto ) Prior Authorization and Quantity Limit Program Summary FDA APPROVED INDICATIONS DOSAGE 1 Indication Entresto Reduce the risk of cardiovascular (sacubitril/valsartan) death

More information

1 National CME on Transplant Critical Care

1 National CME on Transplant Critical Care st 1 National CME on Transplant Critical Care Multi Disciplinary Course Pass on the life... Date : 19th August, 2016 Venue : Max Super Specialty Hospital, Saket, New Delhi About the CME Organ transplantation

More information

Circulatory Support: From IABP to LVAD

Circulatory Support: From IABP to LVAD Circulatory Support: From IABP to LVAD Howard A Cohen, MD, FACC, FSCAI Director Division of Cardiovascular Intervention Co Director Cardiovascular Interventional ti Laboratories Lenox Hill Heart & Vascular

More information

HF QUALITY MEASURES. Hydralazine/nitrate at discharge: Percent of black heart

HF QUALITY MEASURES. Hydralazine/nitrate at discharge: Percent of black heart Get With The Guidelines - Heart Failure is the American Heart Association s collaborative quality improvement program, demonstrated to improve adherence to evidence-based care of patients hospitalized

More information

Heart Failure Management Policy and Procedure Phase 1

Heart Failure Management Policy and Procedure Phase 1 1301 Punchbowl Street, Harkness Suite 225 Honolulu, Hawaii 96813 Phone (808) 691-7220 Fax: (808) 691-4099 www.queenscipn.org Policy and Procedure Phase 1 Policy Number: Effective Date: Revised: Approved

More information

The Approach to Patients with Heart Failure and Mid-Range (40-50%) Ejection Fraction (HFmrEF)

The Approach to Patients with Heart Failure and Mid-Range (40-50%) Ejection Fraction (HFmrEF) The Approach to Patients with Heart Failure and Mid-Range (40-50%) Ejection Fraction (HFmrEF) 22 nd Annual Heart Failure 2018 an Update on Therapy April 21, 2018 Los Angeles, CA Barry Greenberg, M.D. Distinguished

More information

NATIONAL CONFERENCE On Health, Gender and Rural Development: Research, Practice and Policy. Organized By

NATIONAL CONFERENCE On Health, Gender and Rural Development: Research, Practice and Policy. Organized By NATIONAL CONFERENCE On Health, Gender and Rural Development: Research, Practice and Policy Organized By Hyderabad - 500030 In Collaboration with Indian Association of Social Sciences and Health (IASSH)

More information

2017 Summer MAOFP Update

2017 Summer MAOFP Update 2017 Summer MAOFP Update. Cardiology Update 2017 Landmark Trials Change Practice Guidelines David J. Strobl, DO, FNLA Heart Failure: Epidemiology More than 4 million patients affected 400,000 new cases

More information

Clinical Update: Exercise as a Health Prescription

Clinical Update: Exercise as a Health Prescription CLINICAL UPDATES Masterclass Series 2012 2013 Clinical Update: Exercise as a Health Prescription 5.00pm Tuesday, 23 April 2013 Royal College of Physicians of Ireland, No. 6 Kildare Street, Dublin 2 Welcome

More information

PROGRAMME 7 th May. 10 AM To AM Guest Lecture: Dr.Ajit Mullesseri. Stem cell therapy in post myocardial infarction LV dysfunction.

PROGRAMME 7 th May. 10 AM To AM Guest Lecture: Dr.Ajit Mullesseri. Stem cell therapy in post myocardial infarction LV dysfunction. PROGRAMME 7 th May 9AM to 10 AM How to do Learn from the experts Chair persons: Dr.CG.Bahuleyan, Dr.K.Suresh *IABP Dr. Rony Mathew *Interatrial Septal Puncture Dr.Krishnamoorthy K.M. *Septal Ablation in

More information

FRONTLINE CARDIOLOGY. APRIL 21, 2018 College Park Marriott Hotel & Conference Center Hyattsville, MD COURSE DIRECTORS: COURSE CO-DIRECTOR:

FRONTLINE CARDIOLOGY. APRIL 21, 2018 College Park Marriott Hotel & Conference Center Hyattsville, MD COURSE DIRECTORS: COURSE CO-DIRECTOR: 2018 FRONTLINE CARDIOLOGY APRIL 21, 2018 College Park Marriott Hotel & Conference Center Hyattsville, MD COURSE DIRECTORS: Carolina I. Valdiviezo, MD COURSE CO-DIRECTOR: James C. Welsh, MD, MBA, MPH MedStar

More information